microRNA Expression in Renal Cell Carcinoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00743054|
Recruitment Status : Completed
First Posted : August 28, 2008
Last Update Posted : May 21, 2015
|Condition or disease|
|Carcinoma, Renal Cell|
Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biological markers of RCC are needed for early detection, early treatment and improvement of the survival rate of RCC patients.
MiRNA and tumor are closely related. MiRNA can control the important cancer-related genes and participate in the tumor cell proliferation, apoptosis, invasion and angiogenesis.
In this study, RCC related miRNA and the target genes of related miRNA will be examined,and the relationship between RCC related miRNA and the RCC pathological types, TNM (tumor-nodes-metastasis) stages and prognosis will be analyzed. The purpose of this study is to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||microRNA Expression in Renal Cell Carcinoma|
|Study Start Date :||July 2008|
|Actual Primary Completion Date :||August 2009|
|Actual Study Completion Date :||August 2011|
The tumor tissues and tumor adjacent tissues will be collected when patients receive renal cell carcinoma resection.
The blood and urine will be collected before patients receive operation. And the blood and urine of some healthy volunteers will be collected as the control group.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00743054
|The 1st Affiliated Hospital, Sun Yet-sen University|
|GuangZhou, Guangdong, China, 510080|
|Principal Investigator:||Xueqing Yu, M.D. & Ph.D.||1st Affiliated Hospital, Sun Yat-Sen University|